Emmessar Biotech

33.62
+2.62
(8.45%)
Market Cap
16.81 Cr
EPS
1.48
PE Ratio
20.53
Dividend Yield
0.00 %
Industry
Chemicals
52 Week High
64.00
52 Week Low
27.25
PB Ratio
1.99
Debt to Equity
0.01
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
812.40
#1 20,696.40
48.84
#1 15,707.00
-7.64
449
-110.82
39.74
1,136.65
14,348.82
16.76
8,798.90
-22.71
457
#1 318.35
53.70
491.45
7,221.40
14.37
8,398.90
-20.68
485
68.04
43.82
427.05
6,752.07
-
4,003.40
-20.27
-158
45.41
45.27
610.00
5,841.04
#1 9.94
3,498.80
-23.68
#1 794
68.74
44.98
832.95
5,314.38
-
21.50
#1 10,650.00
2
62.50
54.65
625.75
4,595.84
-
3,896.70
-14.52
-237
90.27
58.86
86.45
3,919.78
24.19
1,099.90
9.90
146
0.70
45.36
2,798.00
2,791.03
37.42
385.20
0.60
53
244.55
36.50
255.65
2,617.55
-
2,102.50
-2.77
-39
-82.61
56.56
Growth Rate
Revenue Growth
-10.71 %
Net Income Growth
40.00 %
Cash Flow Change
68.42 %
ROE
33.99 %
ROCE
-23.27 %
EBITDA Margin (Avg.)
-6.69 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
2
2
4
3
2
5
9
2
3
3
3
Expenses
2
2
2
2
1
4
6
1
2
2
2
EBITDA
-0
0
1
1
1
1
2
1
1
1
1
Operating Profit %
-7 %
1 %
9 %
-32 %
-102 %
-12 %
12 %
-245 %
-68 %
-195 %
-282 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
-0
-1
1
1
0
1
2
1
1
1
1
Tax
0
-0
0
-0
-0
0
1
1
1
0
-0
Net Profit
-0
-1
1
1
1
1
1
1
1
1
1
EPS in ₹
-0.24
-0.93
2.36
1.83
1.05
1.51
2.90
0.94
0.99
1.48
1.50

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
2
2
3
4
5
6
8
7
8
9
Fixed Assets
1
1
1
2
2
2
2
2
2
2
Current Assets
1
1
1
1
2
3
5
5
6
7
Capital Work in Progress
0
0
1
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
1
2
2
2
3
4
6
5
6
7
Total Liabilities
2
2
3
4
5
6
8
7
8
9
Current Liabilities
1
1
1
0
1
1
1
0
0
1
Non Current Liabilities
0
1
1
1
1
1
1
1
1
1
Total Equity
1
1
2
3
4
4
6
6
7
7
Reserve & Surplus
-4
-4
-3
-2
-2
-1
1
1
2
2
Share Capital
5
5
5
5
5
5
5
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
0
0
0
1
-0
-0
0
Investing Activities
0
-1
-1
-1
-0
-1
0
-3
-1
-1
Operating Activities
0
0
1
1
0
1
1
2
0
1
Financing Activities
0
0
0
0
0
0
0
0
0
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
58.50 %
58.50 %
58.50 %
58.50 %
58.50 %
58.19 %
58.19 %
58.53 %
59.08 %
59.33 %
59.53 %
59.53 %
59.53 %
59.53 %
59.53 %
59.53 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.20 %
0.20 %
0.20 %
0.20 %
0.20 %
0.20 %
0.20 %
0.20 %
0.20 %
0.20 %
0.20 %
0.20 %
0.20 %
0.20 %
0.20 %
0.20 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
39.61 %
39.41 %
39.26 %
39.26 %
39.12 %
39.56 %
39.54 %
38.85 %
38.38 %
38.22 %
38.20 %
38.13 %
37.94 %
37.64 %
37.48 %
37.09 %
Others
1.70 %
1.89 %
2.05 %
2.05 %
2.18 %
2.05 %
2.07 %
2.43 %
2.35 %
2.25 %
2.07 %
2.15 %
2.33 %
2.64 %
2.80 %
3.19 %
No of Share Holders
6,166
6,311
6,552
6,552
6,999
6,970
6,975
7,024
6,933
6,874
6,822
6,844
7,146
6,900
6,936
7,186

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Closure of Trading Window9 days ago
Newspaper Add For Unaudited Financials For Quarter Ended December 31 2024Feb 07, 2025
Integrated Filing (Financial)Feb 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 06, 2025
Unaudited Financial Results For The Quarter Ended December 31 2024Feb 06, 2025
Board Meeting Outcome for For Unaudited Financial Results For The Quarter Ended December 31 2024Feb 06, 2025
Board Meeting Intimation for For Unaudited Financial Results For The Quarter Ended December 31 2024Jan 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Newspaper AddNov 08, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorNov 07, 2024
Unaudited Financial Results For The Quarter Ended September 30, 2024Nov 07, 2024
Board Meeting Outcome for Unaudited ResultsNov 07, 2024
Clarification On Price MovementNov 07, 2024
Clarification sought from Emmessar Biotech & Nutrition LtdNov 06, 2024
Board Meeting Intimation for Unaudited Results For The Period Ended September 30, 2024Oct 25, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 09, 2024
Closure of Trading WindowSep 28, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 28, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 18, 2024
Newspaper Add Confirming Sending Of Notice Of The 32Nd Annual General Meeting (AGM)Sep 05, 2024
Reg. 34 (1) Annual Report.Sep 04, 2024
Notice Of The 32Nd Annual General Meeting To Be Held On Friday, 27Th September, 2024 At 11:30 A.M. (IST).Sep 04, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 15, 2024
Results-Financial Results For Quarter Ended June 30, 2024Aug 14, 2024
Board Meeting Outcome for Board Meeting Outcome Held On August 14, 2024Aug 14, 2024
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2024Aug 06, 2024
Clarification On Price MovementJul 16, 2024
Clarification sought from Emmessar Biotech & Nutrition LtdJul 15, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 08, 2024
Closure of Trading WindowJun 28, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2024
Results - Financial Results For March 31, 2024May 29, 2024
Board Meeting Outcome for For Results For The Period Ended March 31, 2024May 29, 2024
Board Meeting Intimation for Audited Results For The Period Ended March 31, 2024May 14, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateApr 27, 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 25, 2024
Regulation 7(3) Certificate For Year Ended March 31, 2024Apr 15, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateApr 12, 2024
For The Year Ended March 31, 2024Apr 12, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 12, 2024
Closure of Trading WindowMar 27, 2024
Board Meeting Outcome for Appointment Of Independent DirectorMar 20, 2024
Board Meeting Intimation for Appointment Of Independent DirectorFeb 27, 2024
Board Meeting Outcome for Revised OutcomeFeb 21, 2024
Board Meeting Outcome for Revised OutcomeFeb 16, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 09, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 03, 2024

Technical Indicators

RSI(14)
Neutral
52.14
ATR(14)
Volatile
2.84
STOCH(9,6)
Neutral
33.88
STOCH RSI(14)
Neutral
66.00
MACD(12,26)
Bullish
0.19
ADX(14)
Weak Trend
24.37
UO(9)
Bearish
45.62
ROC(12)
Uptrend And Accelerating
3.45
WillR(14)
Neutral
-32.92